(HealthDay News) — Researchers have withdrawn one of the previous Choosing Wisely recommendations from April 2012, according to a report from the American College of Cardiology (ACC).
In response to new evidence, the ACC has withdrawn one of its Choosing Wisely recommendations suggesting that patients and caregivers should question the use of complete revascularization of all significantly blocked arteries for patients with heart attack.
The previous recommendation, released in April 2012, was based on several non-randomized studies demonstrating harm to patients when treating all significantly blocked arteries. However, results from the Complete Versus Lesion Only Primary-PCI Trial showed better outcomes and fewer major adverse cardiac events for patients undergoing complete vs. target lesion revascularization. These results corroborate data from the Preventive Angioplasty in Myocardial Infarction Trial, released in 2013.
“Science is not static but rather constantly evolving,” ACC President Patrick T. O’Gara, MD, said in a statement. “As such, one of the ACC’s primary roles is to stay abreast of this evolution and provide cardiovascular professionals and patients with the most up-to-date information on which to base decisions about the most appropriate and necessary treatment. The newest findings regarding coronary revascularization are great examples of science on the move, and we are responding accordingly.”